Add to ORKGIncludes bibliographical references.Meningitis is the inflammation of the lining membranes of human brains and spinal cord. It is a deadly disease that has claimed millions of lives throughout the world in particular in developing countries. Neisseria meningitidis serogroup A is among the leading causative agents of meningitis in Sub-Saharan Africa. Its capsular polysaccharide antigen consists of a homopolymer of a-(
The resistance to Neisseria meningitidis (N. m.), a gram-negative bacterium causing meningitis, is m...
Meningitis, a serious communicable inflammatory disease continues to be a worldwide threat especiall...
A novel vaccine against serogroup B meningococcal disease - containing a combination of protein anti...
Synthesis of Neisseria meningitidis serogroup A carba analogues as hydrolytically stable antigens fo...
Background: Meningococcal disease as a worldwide health problem causes approximately 1.2 million ...
This research explores how the meningitis bacteria infect the body, the immune system\u27s response,...
Neisseria meningitidis is a major cause of bacterial meningitis worldwide, especially in the African...
In previous studies protective antibodies that could facilitate bactericidal killing of Neisseria me...
Neisseria meningitidis is a major cause of bacterial meningitis worldwide, especially in the African...
N. meningitidis type X (Men X), first described in the 1960s1, has been found to cause a few cases o...
Neisseria meningitidis is a major cause of bacterial meningitis worldwide, especially in the African...
\(Neisseria\) \(meningitides\) is a major cause of meningitis epidemics in sub-Saharan Africa. A pro...
Towards a Neisseria meningitidis B vaccine Neisseria meningitidis is a bacterium that is only found...
Neisseria meningitidis type A (MenA) is a Gram-negative encapsulated bacterium that may cause expl...
Neisseria meningitidis is a major cause of meningitis and septicaemia in infants and children. Dise...
The resistance to Neisseria meningitidis (N. m.), a gram-negative bacterium causing meningitis, is m...
Meningitis, a serious communicable inflammatory disease continues to be a worldwide threat especiall...
A novel vaccine against serogroup B meningococcal disease - containing a combination of protein anti...
Synthesis of Neisseria meningitidis serogroup A carba analogues as hydrolytically stable antigens fo...
Background: Meningococcal disease as a worldwide health problem causes approximately 1.2 million ...
This research explores how the meningitis bacteria infect the body, the immune system\u27s response,...
Neisseria meningitidis is a major cause of bacterial meningitis worldwide, especially in the African...
In previous studies protective antibodies that could facilitate bactericidal killing of Neisseria me...
Neisseria meningitidis is a major cause of bacterial meningitis worldwide, especially in the African...
N. meningitidis type X (Men X), first described in the 1960s1, has been found to cause a few cases o...
Neisseria meningitidis is a major cause of bacterial meningitis worldwide, especially in the African...
\(Neisseria\) \(meningitides\) is a major cause of meningitis epidemics in sub-Saharan Africa. A pro...
Towards a Neisseria meningitidis B vaccine Neisseria meningitidis is a bacterium that is only found...
Neisseria meningitidis type A (MenA) is a Gram-negative encapsulated bacterium that may cause expl...
Neisseria meningitidis is a major cause of meningitis and septicaemia in infants and children. Dise...
The resistance to Neisseria meningitidis (N. m.), a gram-negative bacterium causing meningitis, is m...
Meningitis, a serious communicable inflammatory disease continues to be a worldwide threat especiall...
A novel vaccine against serogroup B meningococcal disease - containing a combination of protein anti...